Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Niconico Research is the research and development arm of Dwango, a prominent Japanese media and technology company. The organization maintains a specialized Life Science team that applies advanced artificial intelligence, specifically deep learning, to complex biological challenges such as protein structure prediction and computational drug discovery. The team is internationally recognized for its work in protein folding, frequently participating in global benchmarks like the Critical Assessment of Structure Prediction (CASP). By leveraging Dwango's significant high-performance computing infrastructure, Niconico Research aims to accelerate the identification of novel therapeutic targets and the design of new molecules through AI-driven insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NICOVIDEO Research Company.